Re: Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2023;83:145-51

Affiliations

¹ Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China; West China School of Clinical Medicine, Sichuan University, Chengdu, China.
² Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: caodehong@scu.edu.cn.

Comment

Jinze Li et al. Eur Urol. 2023 Sep.

. 2023 Sep;84(3):e75.

doi: 10.1016/j.eururo.2023.04.040. Epub 2023 Jun 1.

¹ Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China; West China School of Clinical Medicine, Sichuan University, Chengdu, China.
² Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: caodehong@scu.edu.cn.

No abstract available

Comment on

Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.
Bakouny Z, El Zarif T, Dudani S, Connor Wells J, Gan CL, Donskov F, Shapiro J, Davis ID, Parnis F, Ravi P, Steinharter JA, Agarwal N, Alva A, Wood L, Kapoor A, Ruiz Morales JM, Kollmannsberger C, Beuselinck B, Xie W, Heng DYC, Choueiri TK. Bakouny Z, et al. Eur Urol. 2023 Feb;83(2):145-151. doi: 10.1016/j.eururo.2022.10.004. Epub 2022 Oct 20. Eur Urol. 2023. PMID: 36272943